1. Amgen
Amgen is a leading human therapeutics company in the biotechnology industry. For more than 25 years, the company has tapped the power of scientific discovery and innovation to advance the practice of medicine. Amgen pioneered the development of novel products based on advances in recombinant DNA and molecular biology and launched the biotechnology industry’s first blockbuster medicines. Today, as a Fortune 500 company serving millions of patients, Amgen continues to be an entrepreneurial, science-driven enterprise dedicated to helping people fight serious illness
2. Genentech
Considered the founder of the biotechnology industry, Genentech has been delivering on the promise of biotechnology for more than 30 years, using human genetic information to discover, develop, manufacture and commercialize biotherapeutics that address significant unmet medical needs. Today, Genentech is among the world's leading biotech companies, with multiple products on the market for serious or life-threatening medical conditions, more than 100 projects in the pipeline and a long term plan for growth. For more general information about the company, visit our corporate overview section.
3. Serono
Merck Serono is the division for innovative small molecules and biopharmaceuticals of Merck KGaA.
Merck Serono’s global headquarters are located in Geneva, Switzerland. In the United States and Canada, the division operates as EMD Serono.
4. Biogen Idec
Scientific excellence that achieves new standards of care drives the company's work. Over 20 products are currently in clinical development addressing a variety of key medical needs In addition to Biogen Idec's promising portfolio of drug candidates, the company's capabilities and capacity for protein manufacturing are world-class in quality and scale. The company is one of a handful of biotechnology companies that has three licensed and dedicated biological bulk-manufacturing facilities, including its large-scale manufacturing plant in Research Triangle Park, NC, which is one of the world's largest cell culture facilities. An additional large-scale manufacturing plant is under construction in Hillerød, Denmark. Biogen Idec has sufficient commercial manufacturing capacity for its own pipeline, as well as potential partners' products.
5. UCB-Celltech
Scientific and technological advances have created a new opportunity to address the complex interconnections of severe diseases much more effectively. The unique combination of expertise in large, antibody-based molecules and small, chemically-derived molecules places us in a strong position to realise this ambition. Cimzia®, our most advanced NBE, targeted at Crohn’s disease and rheumatoid arthritis, is one of the first fruits of this synergy of biology and chemistry.
6. Genzyme
One of the world’s foremost biotechnology companies, Genzyme is dedicated to making a major positive impact on the lives of people with serious diseases. Founded in Boston in 1981, Genzyme has grown from a small start-up to a diversified enterprise with annual revenues exceeding $3 billion and 10,000 employees in locations spanning the globe.With many established products and services helping patients in nearly 90 countries, Genzyme is a leader in the effort to develop and apply the most advanced technologies in the life sciences. The company’s products and services are focused on rare inherited disorders, kidney disease, orthopaedics, transplant, cancer, and diagnostic testing. Genzyme’s commitment to innovation continues today with a substantial research and development program focused on these fields, as well as immune disease, infectious disease, and other areas of unmet medical need.
7. Gilead
Since 1987, Gilead Sciences has worked to discover, develop and commercialize medications to advance the care of patients suffering from life-threatening diseases in areas of unmet medical need.Headquartered in Foster City, California, the company has expanded rapidly over the past two decades, with annual revenues now exceeding $4 billion, operations spanning three continents (North America, Europe and Australia) and a staff of more than 2,900 employees.Gilead’s primary areas of focus include: antivirals (such as HIV/AIDS and chronic hepatitis), cardiovascular conditions (such as pulmonary arterial hypertension and resistant hypertension) and respiratory diseases (such as influenza and cystic fibrosis).Our growing pipeline includes novel investigational medications for resistant hypertension, cystic fibrosis, HIV and hepatitis.To begin learning more about Gilead Sciences, view Gilead-at-a-Glance.
8. MedImmune
MedImmune strives to provide better medicines to patients, new medical options for physicians, rewarding careers to employees, and increased value to shareholders. Dedicated to advancing science and medicine to help people live better lives, the company is focused on the areas of infectious diseases, cancer and inflammatory diseases. The company has three marketed products and an advancing pipeline of promising candidates, all designed to treat or prevent a number of debilitating or life-threatening diseases. MedImmune's state-of-the-art R&D facility and worldwide corporate headquarters is located in Gaithersburg, Maryland.With approximately 3,000 employees worldwide, MedImmune is headquartered in Maryland with facilities in Pennsylvania, California, Kentucky, the United Kingdom and the Netherlands. The company relocated its corporate headquarters to a new state-of-the-art facility in March 2004, designed to place research functions at the core and enhance the collaborative potential of researchers and developers.The company's marketed products include Synagis® (palivizumab), Ethyol® (amifostine), and FluMist® (Influenza Virus Vaccine Live, Intranasal), with additional products in clinical testing.
9. Chiron
Chiron, a business of Novartis Vaccines and Diagnostics, has a legacy of leadership in blood safety since 1986, when Chiron scientists first identified the hepatitis C virus leading to the development of the first test to screen blood for HCV.Select your location below for the latest news and information on Chiron and the PROCLEIX® line of nucleic acid testing (NAT) products for blood screening.
10. Millennium
Millennium Pharmaceuticals currently markets a leading oncology product, VELCADE® (bortezomib) for Injection. Millennium expects to develop drugs in two key therapeutic areas:
Cancer
Inflammation
The company also has a significant number of investigational drugs at various stages of clinical and preclinical development, as described in the R&D section of this website.
Friends,
This is we are just sharing the information we got from one website.
We will update more in this regards. We need your co-operations.
Thanking you,
admin@sathya.org.in
response@sathya.org.in
Posts
